Prospective evaluation of aldosterone LC-MS/MS-specific cutoffs for the saline infusion test.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 13 01 2020
accepted: 26 05 2020
pubmed: 28 5 2020
medline: 2 7 2020
entrez: 28 5 2020
Statut: ppublish

Résumé

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) has become state of the art for the quantitative analysis of steroid hormones. Although method comparisons show that aldosterone measurement using LC-MS/MS yields considerably lower levels than immunoassays (IAs), method-specific cutoff values for primary aldosteronism (PA) are largely missing. Objective of this study was to analyze the diagnostic accuracy of proposed LC-MS/MS-specific cutoff values for the saline infusion test (SIT). From 2016 to 2019, 104 consecutive patients suspected of PA underwent the SIT and captopril challenge test in the tertiary medical center at the University Hospital of Leipzig, Germany. Patients with positive case confirmation underwent adrenal imaging and adrenal venous sampling for subtype classification. Overall, proposed assay-specific PACLC-MS/MS cutoff values for the SIT achieved higher diagnostic accuracy than established PACIA values with a sensitivity and specificity of 87.5% (95% CI: 71.0-96.5) and 97% (95% CI: 89.6-99.6) for a cutoff of 120 pmol/L and 93.8% (95% CI: 79.2-99.2) and 92.5% (95% CI: 83.4-97.5) for a cutoff of 94 pmol/L. The most accurate post-SIT PACLC-MS/MS cutoff value in this study was 83 pmol/L, yielding a sensitivity and specificity of 96.9% (95% CI: 83.8-99.9) and 92.5% (95% CI: 83.4-97.5), respectively. The present data confirm the need for the implication of lower method-specific aldosterone cutoff values for the diagnosis of PA with LC-MS/MS based aldosterone measurement.

Identifiants

pubmed: 32460235
doi: 10.1530/EJE-20-0030
pii: EJE-20-0030
doi:
pii:

Substances chimiques

Angiotensin-Converting Enzyme Inhibitors 0
Saline Solution 0
Aldosterone 4964P6T9RB
Captopril 9G64RSX1XD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-201

Auteurs

Charlotte Michaela Fries (CM)

Medical Department III, Endocrinology, Nephrology, Rheumatology, University Hospital of Leipzig, Leipzig, Germany.

Yoon Ju Bae (YJ)

Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University of Leipzig, Leipzig, Germany.

Nada Rayes (N)

Endocrine Surgery, Department for Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.

Benjamin Sandner (B)

Medical Department III, Endocrinology, Nephrology, Rheumatology, University Hospital of Leipzig, Leipzig, Germany.

Berend Isermann (B)

Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University of Leipzig, Leipzig, Germany.

Michael Stumvoll (M)

Medical Department III, Endocrinology, Nephrology, Rheumatology, University Hospital of Leipzig, Leipzig, Germany.

Valentina Fagotto (V)

Department of Medicine IV, Klinikum der Universität, Ludwig-Maximilians-Universität, München, Germany.

Martin Reincke (M)

Department of Medicine IV, Klinikum der Universität, Ludwig-Maximilians-Universität, München, Germany.

Martin Bidlingmaier (M)

Department of Medicine IV, Klinikum der Universität, Ludwig-Maximilians-Universität, München, Germany.

Vogel Mandy (V)

Leipzig Research Center for Civilization Diseases (LIFE Child), University of Leipzig, Leipzig, Germany.

Jürgen Kratzsch (J)

Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University of Leipzig, Leipzig, Germany.

Wiebke Kristin Fenske (WK)

Medical Department III, Endocrinology, Nephrology, Rheumatology, University Hospital of Leipzig, Leipzig, Germany.
Integrated Research and Treatment Centre for Adiposity Diseases, Department of Medicine, University of Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH